9M 2018 Results Press Release

Download our press release published on 6 November to find out the financial results for the first nine months of 2018.


No votes yet
 
Related
ROVI reports operating revenue growth of 24% and EBITDA growth of 25% • Operating revenue increased by 24% to 575.5 million euros driven...
3 min
04/11/2022
On his visit to the plant, which is ready to start production as soon as the authorisation from the Spanish Agency of Medicines and...
4 min
24/10/2022
Glicopepton Biotech founded to produce compounds of high technological value   · ROVI, Càrniques Celrà and Grupo Costa announce...
3 min
04/10/2022